🎥 Inside Faraday Earth’s bid to make cheap green ammonia without Haber-Bosch
[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Faraday Earth] Can a container-sized plasma reactor…
CPEW 2026参会阵容发布，与行业先锋共话全球增量
2026年，中国农药行业正式迈入″创制元年″，从″成本竞争″转向″技术竞争″，从″跟跑仿制″到″创制引领″，行业正站在新的分水岭上。在供应链区域化重构与绿色壁垒升级的双重挑战下，唯有具备核心创新能力与全球视野的企业，才能在新一轮周期中抢占先机。
The biggest biotech funding rounds in June 2026
The companies Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026 across private and public funding types. In this article, we break down last month’s private and public fundraising activity, looking at the largest rounds in more detail.
Novartis buys UK ADC biotech Myricx Bio in up to $1.5bn deal
Why it matters: ADCs have become one of oncology’s hottest dealmaking areas, but much of the field still relies on a limited set of payload classes, including topoisomerase-1 and tubulin inhibitors.
Guest Post: The Biggest FoodTech AI Revolution Is Happening Out of Sight
Lore De Valck is a Programme Manager at biotope by VIB, an early-stage investor and accelerator supporting biotech startups with a positive impact on planetary health. In this role, she contributes to biotope’s work helping early-stage founders grow their ventures within a dedicated biotech ecosystem. Her experience encompasses biotech entrepreneurship, strategy consulting and life sciences innovation, including experience at Bain & Company and KQ Labs, the Francis Crick Institute’s accelerator for data-driven health startups. Lore holds an MSc in Bioscience Entrepreneurship from University College London.
Kimberly-Clark and Suzano launch hygiene giant Arbex
Suzano and Kimberly-Clark have created Arbex, a new global tissue and hygiene company. The brand was formed as a US$3.4 billion joint venture between the two and has commenced independent operations, unveiling its brand, leadership, and corporate structure.
Electrickle: Hutton Researchers Developing Wastewater Treatment Process To Improve Efficiency And Cut Greenhouse Gas Emissions
July 2026, UK: Researchers at The James Hutton Institute, Scotland’s pre‑eminent interdisciplinary research institute fo…
From ‘cautiously optimistic’ to ‘hollow words,’ agrifood weighs in on the US regen ag executive order
By now, plenty of agrifood industry folks have weighed in on the Advancing Regenerative Agriculture and Strengthening Am…
泰禾股份公告嘧菌酯、肟菌酯原药募投项目建成并结项
世界农化网中文网报道：7月2日，南通泰禾化工股份有限公司（简称″泰禾股份″）发布公告称，公司募投项目″嘧菌酯原药项目″和″肟菌酯原药项目″建成并达到预定可使用状态，公司决定项目进行结项。
Genentech signs $490m breast cancer deal with Astex
By the numbers: The R&D deal with Roche’s Genentech is worth more than $490 million plus royalties and will draw on Astex’s fragment-based drug discovery technology to target a cell-cycle-dependent regulator in breast cancer.